Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Gender differences in serum testosterone and cortisol in patients with major depressive disorder compared with controls.

Matsuzaka H, Maeshima H, Kida S, Kurita H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H.

Int J Psychiatry Med. 2013;46(2):203-21.

PMID:
24552043
2.

Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls.

Kurita H, Maeshima H, Kida S, Matsuzaka H, Shimano T, Nakano Y, Baba H, Suzuki T, Arai H.

J Affect Disord. 2013 Apr 5;146(2):205-12. doi: 10.1016/j.jad.2012.09.004.

PMID:
23102506
3.

HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression.

Holsen LM, Lancaster K, Klibanski A, Whitfield-Gabrieli S, Cherkerzian S, Buka S, Goldstein JM.

Neuroscience. 2013 Oct 10;250:733-42. doi: 10.1016/j.neuroscience.2013.07.042.

4.

RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.

Liu X, Kakeda S, Watanabe K, Yoshimura R, Abe O, Ide S, Hayashi K, Katsuki A, Umeno-Nakano W, Watanabe R, Ueda I, Moriya J, Nakamura J, Korogi Y.

Depress Anxiety. 2015 Sep;32(9):702-8. doi: 10.1002/da.22401.

PMID:
26290363
5.

Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.

Tanaka Y, Ishitobi Y, Maruyama Y, Kawano A, Ando T, Okamoto S, Kanehisa M, Higuma H, Ninomiya T, Tsuru J, Hanada H, Kodama K, Isogawa K, Akiyoshi J.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30;36(2):220-4. doi: 10.1016/j.pnpbp.2011.10.005.

PMID:
22063648
6.

HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.

Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.

Psychoneuroendocrinology. 2009 Jan;34(1):99-109. doi: 10.1016/j.psyneuen.2008.08.018.

PMID:
18829172
8.

Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.

Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.

J Affect Disord. 2013 Dec;151(3):1108-12. doi: 10.1016/j.jad.2013.06.049.

PMID:
23866302
9.

[Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].

Ozsoy S, Eşel E, Hacimusalar Y, Candan Z, Kula M, Turan T.

Turk Psikiyatri Derg. 2008 Winter;19(4):341-8. Turkish.

10.

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016.

PMID:
24096053
11.

Relationship between hypothalamic-pituitary-adrenal axis dysregulation and insulin resistance in elderly patients with depression.

Yokoyama K, Yamada T, Mitani H, Yamada S, Pu S, Yamanashi T, Matsumura H, Nakagome K, Kaneko K.

Psychiatry Res. 2015 Apr 30;226(2-3):494-8. doi: 10.1016/j.psychres.2015.01.026.

12.

Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression.

Behnken A, Bellingrath S, Symanczik JP, Rieck MJ, Zavorotnyy M, Domschke K, Arolt V, Zwanzger P.

Psychoneuroendocrinology. 2013 Mar;38(3):447-54. doi: 10.1016/j.psyneuen.2012.07.005.

PMID:
22840287
13.

Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.

Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.

Arch Gen Psychiatry. 2009 Jun;66(6):617-26. doi: 10.1001/archgenpsychiatry.2009.50.

PMID:
19487626
14.

Low 24-hour adiponectin and high nocturnal leptin concentrations in a case-control study of community-dwelling premenopausal women with major depressive disorder: the Premenopausal, Osteopenia/Osteoporosis, Women, Alendronate, Depression (POWER) study.

Cizza G, Nguyen VT, Eskandari F, Duan Z, Wright EC, Reynolds JC, Ahima RS, Blackman MR; POWER Study Group..

J Clin Psychiatry. 2010 Aug;71(8):1079-87. doi: 10.4088/JCP.09m05314blu.

15.

Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity.

Vicennati V, Ceroni L, Genghini S, Patton L, Pagotto U, Pasquali R.

Obesity (Silver Spring). 2006 Feb;14(2):235-43.

16.

The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.

Rybakowski JK, Twardowska K.

J Psychiatr Res. 1999 Sep-Oct;33(5):363-70.

PMID:
10504004
17.

The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma.

Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB.

Biol Psychiatry. 2008 Feb 15;63(4):398-405.

PMID:
17825799
18.

Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder.

Posener JA, Charles DeBattista, Veldhuis JD, Province MA, Williams GH, Schatzberg AF.

Psychoneuroendocrinology. 2004 Oct;29(9):1129-37.

PMID:
15219636
19.

Psychological coping in depressed outpatients: association with cortisol response to the combined dexamethasone/CRH test.

Hori H, Teraishi T, Ota M, Hattori K, Matsuo J, Kinoshita Y, Ishida I, Nagashima A, Koga N, Higuchi T, Kunugi H.

J Affect Disord. 2014 Jan;152-154:441-7. doi: 10.1016/j.jad.2013.10.013.

PMID:
24210627
20.

The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.

Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.

Eur Neuropsychopharmacol. 2009 Jun;19(6):409-15. doi: 10.1016/j.euroneuro.2009.02.007.

PMID:
19327969

Supplemental Content

Support Center